Denosumab 60.00 mg

DENAXA INJ is a prefilled syringe containing 60.00mg of Denosumab. It is a monoclonal antibody that helps to prevent bone fractures and other skeletal-related events in patients with certain bone disorders. Denosumab works by inhibiting the action of a protein called RANKL (Receptor Activator of Nuclear Factor-Kappa B Ligand), which plays a crucial role in the breakdown of bone tissue. By preventing excessive bone resorption, DENAXA INJ can help improve bone density and reduce the risk of fractures in patients. It is typically used in the treatment of osteoporosis and certain types of cancer that have metastasized to the bone.

This medication is administered as a subcutaneous injection. It is usually given once every 6 months, following the instructions provided by a healthcare professional.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.